Varenicline for treatment of e-cigarette dependence
- Study HIC#:2000032740
- Last Updated:09/20/2023
This study aims to understand if varenicline can help people who regularly use e-cigarettes stop or reduce vaping. Participants will receive an 8-week supply of either varenicline or a matching placebo and answer weekly questionnaires. The study is fully remote and involvement lasts 12-weeks. Compensation of up to $185 is provided.
Link to go directly to the prescreener here: https://redcap.musc.edu/surveys/?s=8HWXTWHK3WPDHA4T
Study Coordinators:
- Ali Serrantino; 203-464-7850; alison.serrantino@yale.edu
- Rebecca Marrero; 203-464-7135; rebecca.marrero@yale.edu
- Lab email: tobaccostudy@yale.edu
- Age18 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Alison Serrantino
- Phone Number: 1-203-464-7850
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
This study aims to understand if varenicline can help people who regularly use e-cigarettes stop or reduce vaping. Participants will receive an 8-week supply of either varenicline or a matching placebo and answer weekly questionnaires. The study is fully remote and involvement lasts 12-weeks. Compensation of up to $185 is provided.
Link to go directly to the prescreener here: https://redcap.musc.edu/surveys/?s=8HWXTWHK3WPDHA4T
Study Coordinators:
- Ali Serrantino; 203-464-7850; alison.serrantino@yale.edu
- Rebecca Marrero; 203-464-7135; rebecca.marrero@yale.edu
- Lab email: tobaccostudy@yale.edu
Eligibility Criteria
Inclusion:
- age 18+
- Daily use of an e-cigarette (>25 days in last month) for >6 months
- Desire to quit e-cigarettes
- Daily access to a smartphone or regular access to/use of email
- Live in SC or CT
- No use of combustible or non-combustible tobacco/nicotine products in the past 30 days
Exclusion:
- Vulnerable populations/individuals incapable of providing their own consent
- Medical contraindications for varenicline use
- Current use of smoking cessation medication (NRT, meds, etc.)
- Have a household member currently enrolled in study
- Not proficient in English
- Pregnant individuals (female participants <55 will be sent pregnancy test to confirm non-pregnancy)
